Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Regina E. Abotsi, Mark P. Nicol, Grace McHugh, Victoria Simms, Andrea M. Rehman, Charmaine Barthus, Lucky G. Ngwira, Brenda Kwambana-Adams, Robert S. Heyderman, Jon Ø. Odland, Rashida A. Ferrand, Felix S. Dube. The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease. ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021

Member's Comments

No comment yet.

Related content which might interest you: Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Long-term macrolide treatment for chronic respiratory disease Source: Eur Respir J 2013; 42: 239-251 Year: 2013 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Bacteria, antibiotics and COPD Source: Eur Respir J 2001; 17: 995-1007 Year: 2001 Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001 Efficacy of low-dose, long-term clarithromycin administration in improving the clinical course in cystic fibrosis patients with chronic P. aeruginosa airway colonization Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003 The clinical impact of adherence to therapy in airways disease Source: Breathe, 17 (2) 210039; 10.1183/20734735.0039-2021 Year: 2021 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD Source: Eur Respir J 2009; 34: 1066-1071 Year: 2009 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Effect of azithromycin treatment on inflammation in COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: management Year: 2010 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003